Skip to main content
Fig. 2 | Clinical Epigenetics

Fig. 2

From: Evaluation of global and intragenic hypomethylation in colorectal adenomas improves patient stratification and colorectal cancer risk prediction

Fig. 2

Methylation assays in high-risk and low-risk patients. Adenomas were considered non-hypomethylated (in dark gray) when assays showed methylation levels above 60%. Adenomas were considered hypomethylated (in white) when assays displayed methylation level below 60%. a Global L1 methylation assay. b Intragenic L1-MET methylation assay. c Combination of the two methylation assays: we consider hypomethylated patients with at least one assay below 60%

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us